The impact of ethnicity, educational and economic status on the prescription of insulin therapeutic regimens and on glycemic control in patients with type 1 diabetes. A nationwide study in Brazil

Imagem de Miniatura
Arquivos
art_GOMES_The_impact_of_ethnicity_educational_and_economic_status_2017.PDF (434.28 KB)
Citações na Scopus
16
Tipo de produção
article
Data de publicação
2017
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER IRELAND LTD
Autores
GOMES, Marilia Brito
RODACKI, Melanie
PAVIN, Elizabeth Joao
COBAS, Roberta Arnoldi
FELICIO, Joao S.
ZAJDENVERG, Lenita
NEGRATO, Carlos Antonio
Citação
DIABETES RESEARCH AND CLINICAL PRACTICE, v.134, p.44-52, 2017
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Aims: Establish the relationship between demographic, educational and economic status on insulin therapeutic regimens (ITRs) and on glycemic control in patients with type 1 diabetes. Methods: This was a cross-sectional, multicenter study with 1760 patients conducted between August 2011 and August 2014 in 10 Brazilian cities. Results: Patients were stratified according to ITRs as follows: only NPH insulin (group 1, n = 80(4.5%)); only long-acting insulin analogs (group 2, n = 6(0.3%)); continuous subcutaneous insulin infusion (CSII) (group 3, n = 62(3.5%)); NPH plus regular insulin (group 4, n = 710(40.3%)); NPH plus ultra-rapid insulin analogs (group 5, n = 259(14.8%)); long-acting insulin analogs plus regular insulin (group 6, n = 25(4.4%)) and long-acting plus ultrarapid insulin analogs (group 7, n = 618 (35.1%)). As group A (provided free of charge by the government) we considered groups 1 and 4, and as group B (obtained through lawsuit or out-of-pocket) groups 2, 3 and 7. Results: Multivariate logistic analysis showed that independent variables related to group B were older age, more years of school attendance, higher economic status and ethnicity (Caucasians). The independent variables related to better glycemic control were older age, higher adherence to diet, higher frequency of self-monitoring of blood glucose, more years of school attendance and belonging to group B. Conclusions: In Brazilian National Health Care System, prescriptions of insulin analogs or CSII are more frequent in Caucasian patients with type 1 diabetes, with higher economic status and more years of school attendance. Among these variables years of school attendance was the only one associated with better glycemic control.
Palavras-chave
Type 1 diabetes, Glycemic control, Insulin therapeutic regimens
URI
https://observatorio.fm.usp.br/handle/OPI/28010
Referências
  1. ABEP, 2010, BRAZ EC CLASS CRIT
  2. [Anonymous], 2015, DIABETES CARE, V38, pS70, DOI 10.2337/dc15-S014
  3. [Anonymous], 2014, DIABETES CARE, V37, P9
  4. Chillaron JJ, 2014, METABOLISM, V63, P181, DOI 10.1016/j.metabol.2013.10.002
  5. Cobas RA, 2013, B WORLD HEALTH ORGAN, V91, P434, DOI 10.2471/BLT.12.110387
  6. Conway B, 2010, DIABETIC MED, V27, P398, DOI 10.1111/j.1464-5491.2010.02956.x
  7. Coulon SJ, 2016, PEDIAT DIABETES, V18
  8. Davison KAK, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-19
  9. DeVries JH, 2015, DIABETES OBES METAB, V17, P445, DOI 10.1111/dom.12410
  10. Donnelly LA, 2005, DIABETIC MED, V22, P749, DOI 10.1111/j.1464-5491.2005.01501.x
  11. Gibb FW, 2016, DIABETOLOGIA, V59, P2082, DOI 10.1007/s00125-016-4034-0
  12. Gill GV, 2011, DIABETOLOGIA, V54, P19, DOI 10.1007/s00125-010-1897-3
  13. Giuffrida FM, 2016, DIABETOL METAB SYNDR, V22, P8
  14. Gomes MB, 2016, DIABETES RES CLIN PR, V120, P47, DOI 10.1016/j.diabres.2016.07.011
  15. Gomes MB, 2013, DIABETIC MED, V30, P1255, DOI 10.1111/dme.12236
  16. Gomes MB, 2013, ACTA DIABETOL, V50, P743, DOI 10.1007/s00592-012-0404-3
  17. Gomes MB, 2012, DIABETES RES CLIN PR, V97, P63, DOI 10.1016/j.diabres.2012.02.008
  18. Hood KK, 2009, PEDIATRICS, V124, pE1171, DOI 10.1542/peds.2009-0207
  19. International Diabetes Federation, 2013, IDF DIABETES ATLAS
  20. Kim H, 2012, J CLIN RES PEDIATR E, V4, P82, DOI [10.4274/jcrpe.663, 10.4274/Jcrpe.663]
  21. Malerbi FEK, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-48
  22. Maahs DM, 2015, DIABETES CARE, V38
  23. MALERBI DA, 1992, DIABETES CARE, V15, P1509, DOI 10.2337/diacare.15.11.1509
  24. Marra LP, 2016, DIABETES THER, V7, P241, DOI 10.1007/s13300-016-0166-y
  25. Marra LP, CLIN EFFECTIVENESS I
  26. Murata T, 2015, J DIABETES INVEST, V6, P687, DOI 10.1111/jdi.12362
  27. Seaquist ER, 2013, DIABETES CARE, V36, P1384, DOI 10.2337/dc12-2480
  28. Shrestha SS, 2011, DIABETES CARE, V34, P1097, DOI 10.2337/dc10-2177
  29. Simonetti JA, 2014, DIABETES CARE, V37, P993, DOI 10.2337/dc13-1332
  30. STEPHENSON J, 1994, DIABETOLOGIA, V37, P278, DOI 10.1007/BF00398055
  31. van Duinkerken E, 2014, DIABETES CARE, V37, P2483, DOI 10.2337/dc14-0016
  32. Wagner DV, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-015-0606-5
  33. WHO. World Health Organization, 2000, WHO OB TECHN REP SER, V284, P256
  34. Willi SM, 2015, PEDIATRICS, V135, P424, DOI 10.1542/peds.2014-1774
  35. Wood JR, 2013, DIABETES CARE, V36, P2035, DOI 10.2337/dc12-1959
  36. Yeh HC, 2012, ANN INTERN MED, V157, P336, DOI 10.7326/0003-4819-157-5-201209040-00508

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCM
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/18
Artigos e Materiais de Revistas Científicas - ODS/03